To study the Effect of Laghu Manjisthadi Kashaya in Sheetapitta (Urticaria)

A Randomised Controlled Clinical Study to evaluate the Efficacy of Laghu Manjisthadi Kashaya in the Management of Sheetapitta (Urticaria) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103556

Enrollment

Registered

2026-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects with classical signs and symptoms of Sheetapitta like- Mandala, Kotha, Kandu, Toda, Daha, Jwara, Chardi. 2 Subject in the age group of 21-60 years irrespective of Gender, Religion and Socio economic status. 3 Both Freshly diagnosed and known cases of Sheetapitta are included in study. 4 Subject Willing to take part in the study with informed written consent.

Exclusion criteria

Exclusion criteria: 1 Subjects having any major systemic illness. 2 Pregnancy or Lactating Women 3 Subjects with relative comorbidities like DM, HTN, HIV. 4 Urticaria as a part of systemic anaphylaxis reaction which is life threatening. 5 Drugs induced urticaria 6 Patients suffering from other skin diseases like Eczema, Psoriasis.

Design outcomes

Primary

Measure	Time frame
Effect of Trial Drug on Improvement in the symptoms of Sheetapitta (Urticaria)Timepoint: 7day,15day,30day	—

Secondary

Measure	Time frame
Saftey of Trial drug and Adverse Drug Reaction Aggravation of symptoms of Sheetapitta(Urticaria)Timepoint: 7day,15day,30day	—

Countries

India

Contacts

Public ContactDr Anjali Shankarrao Mane

SDMTs AMC Post Graduation Centre Terdal

vaidyasukumar@gmail.com9986125625

Outcome results